Control strategies for synthetic therapeutic peptide APIs – Part I: Analytical consideration
![](https://www.polypeptide.com/wp-content/uploads/2022/09/polypeptide-logo.png)
Expert views
By Aleksander Swietlow,Harold Rode,Anita Szajek,Michael Verlander,Ivo Eggen,Brian Gregg; BioPharm International, Apr 2014
By Aleksander Swietlow,Harold Rode,Anita Szajek,Michael Verlander,Ivo Eggen,Brian Gregg; BioPharm International, Apr 2014